Hrt Financial LP Gossamer Bio, Inc. Transaction History

Hrt Financial LP

$12.8 Billion
Q1 2025

A detailed history of Hrt Financial LP transactions in Gossamer Bio, Inc. stock. As of the latest transaction made, Hrt Financial LP holds 389,452 shares of GOSS stock, worth $498,498. This represents 0.0% of its overall portfolio holdings.

Number of Shares

389,452

Holding current value

$498,498

% of portfolio

0.0%

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2025 May 15, 2025	BUY	$0.85 - $1.53 $331,034 - $595,861	389,452 New	389,452 $428,000
Q1 2024 May 13, 2024	BUY	$0.8 - $1.51 $439,794 - $830,111	549,743 Added 4462.92%	562,061 $663,000
Q4 2023 Feb 09, 2024	BUY	$0.48 - $1.08 $5,912 - $13,303	12,318 New	12,318 $11,000
Q1 2023 May 12, 2023	BUY	$0.96 - $2.92 $1.49 Million - $4.52 Million	1,548,153 New	1,548,153 $1.95 Million
Q2 2022 Aug 12, 2022	SELL	$5.97 - $9.97 $60,744 - $101,444	-10,175 Closed	0 $0
Q1 2022 May 16, 2022	SELL	$8.44 - $12.49 $12,288 - $18,185	-1,456 Reduced 12.52%	10,175 $88,000
Q4 2021 Feb 14, 2022	SELL	$10.12 - $14.07 $56,368 - $78,369	-5,570 Reduced 32.38%	11,631 $131,000
Q3 2021 Nov 15, 2021	BUY	$7.25 - $13.23 $124,707 - $227,569	17,201 New	17,201 $216,000
Q2 2021 Aug 16, 2021	SELL	$8.0 - $9.75 $96,328 - $117,399	-12,041 Closed	0 $0
Q1 2021 May 17, 2021	BUY	$8.63 - $10.94 $103,913 - $131,728	12,041 New	12,041 $111,000

Others Institutions Holding GOSS

# of Institutions

127

Shares Held

162M

Call Options Held

2.11M

Put Options Held

57.8K

Octagon Capital Advisors LP New York, NY

18.4M
Shares

$23.5 Million
6.72% of portfolio
Nea Management Company, LLC Timonium, MD

18.1M
Shares

$23.2 Million
1.89% of portfolio
Vanguard Group Inc Valley Forge, PA

10.1M
Shares

$12.9 Million
0.0% of portfolio
Arch Venture Management, LLC Chicago, IL

8.06M
Shares

$10.3 Million
7.27% of portfolio
Acadian Asset Management LLC Boston, MA

6.36M
Shares

$8.14 Million
0.02% of portfolio

View Full List

About Gossamer Bio, Inc.

Ticker GOSS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 93,954,000
Market Cap $120M
Description
Gossamer Bio, Inc., a clinical-stage biopharmaceutical company, focuses on discovering, acquiring, developing, and commercializing therapeutics in the disease areas of immunology, inflammation, and oncology in the United States. The company is developing GB002, an inhaled, small molecule, platelet-derived growth factor receptor, or PDGFR, colony...

More about GOSS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Hrt Financial LP, based on Form 13F filings with the SEC.

News

Stay updated on Hrt Financial LP with notifications on news.

Account